6 THINGS TO KNOW ABOUT
PT-141
The friendly visual guide to the desire-first shot
Betty: Hi! I’m Betty. Fun twist — PT-141 started life as a tanning shot. Researchers testing it for sun-free color spotted something they weren’t looking for: it turned up desire. It works upstream, high in the brain where wanting begins — not downstream on blood flow like the erection pills. Six quick things and you’ll get the whole picture.
Ace: Here’s the deeper why. Your brain has desire signals called the melanocortin system. They help switch arousal on. PT-141 (bremelanotide, sold as Vyleesi) gives those signals a nudge1. So it works up in the brain, not on blood flow. That’s why the FDA (the US agency that approves medicines) approved it in 2019 for HSDD — ongoing low sexual desire that bothers you — in women before menopause2. For men it’s off-label: a doctor can prescribe it, but the FDA hasn’t approved it.
Betty: You made it! The short version: PT-141 is FDA-approved for premenopausal women with HSDD (that ongoing low desire that bothers you), and it works upstream in the brain — on the wanting, not the plumbing. One small shot, at least 45 minutes before intimacy, only when you need it. About 4 in 10 people feel queasy, mostly the first time — so team up with a doctor and plan an easy first try.
What PT-141 Is
It began as a tanning shot — then came the surprise.
Also called bremelanotide — sold as Vyleesi®
Works on your sex drive, not just the physical side
A small shot when you need it — not a daily pill
One of the few options used for men & women
It Works in the Brain
Erection pills work on blood flow. PT-141 works on the wanting itself.
ED pills (pills for erection trouble) — boost blood flow and handle the physical side only
PT-141 — turns on a desire signal in the brain, going after wanting it
What It Feels Like
It doesn’t make desire appear from nowhere — it lowers the bar.
Touch that wouldn’t be enough starts to work again
Brings back a feeling you used to have — not something brand new
Who It’s For
Low desire, not performance
Men & women
Desire dipped from stress
Want a brain-based option
How People Use It
As-needed, not every day.
A small shot under the skin, at least 45 minutes before intimacy
Most feel it in 45–60 minutes; the effect can last several hours
Good to Know
A prescription medicine — start low and see how you react.
Nausea is the most common side effect, usually worst the first time3
A licensed clinician (a doctor or nurse who can write prescriptions) prescribes it; FDA-approved for women before menopause
Common questions about Bremelanotide (PT-141)
Short answers to what people search for most. The sections above have the full picture.
What is Vyleesi approved for?
Vyleesi® (bremelanotide) was approved by the FDA in 2019 for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) — low desire that causes distress and isn't explained by another condition, medication or relationship problem. HSDD, explained →
Is PT-141 approved for men or for erectile dysfunction?
No. Bremelanotide was studied in men years ago, but the only FDA-approved use is HSDD in premenopausal women. PT-141 marketed to men is compounded or sold as "research" material and hasn't been reviewed for that use. Approved options for ED →
How is it taken?
A single 1.75 mg dose from an autoinjector under the skin of the abdomen or thigh, at least 45 minutes before anticipated sexual activity. The label limits it to one dose in 24 hours and no more than eight doses a month. The full Vyleesi guide →
What are the side effects?
Nausea is the big one — about 40% of women in the trials had it, most often after the first dose. Flushing, injection-site reactions and headache are also common. It causes a temporary rise in blood pressure, so it isn't used in people with uncontrolled high blood pressure or known heart disease, and repeated use can darken patches of skin (focal hyperpigmentation).
How is it different from Viagra?
Viagra and similar pills act on blood flow. Bremelanotide acts in the brain, on melanocortin receptors involved in sexual desire. Different problem, different mechanism.
Is bremelanotide a peptide?
Yes — a cyclic seven-amino-acid peptide modeled on the natural hormone alpha-MSH. Clinical evidence for bremelanotide →
Sources
Every number on this page traces back to one of these — FDA labels and announcements, peer-reviewed trials, and clinical references.
Want to see your options?
Explore the full rundown of sexual-wellness treatments and find a provider that fits you.
Compare sexual wellness providers →Important: This guide is for education only and isn’t medical advice — always talk to a licensed physician before starting, stopping, or changing any medication. PT-141 (bremelanotide) is FDA-approved for low sexual desire in women who haven’t gone through menopause; use in men is off-label (outside the approved use) and not FDA-approved. We may earn a commission from links to providers, which never influences our recommendations.
Different peptides, different jobs. Which one are you trying to learn about?
Not sure? Take the 60-second quiz →
Comments